Shi X - Search Results

1

Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis.

Lu X, Zhu C, Gao Y, Yu Z, Yan Q, Liu Y, Luo M, Shi X. Lu X, et al. Among authors: shi x. Bioorg Chem. 2024 Feb;143:107018. doi: 10.1016/j.bioorg.2023.107018. Epub 2023 Dec 6. Bioorg Chem. 2024. PMID: 38071874

2

Synthesis and structure-activity relationships of pirfenidone derivatives as anti-fibrosis agents in vitro.

Shi X, Yu Z, Zhu C, Jiang L, Geng N, Fan X, Guan Z, Lu X. Shi X, et al. RSC Med Chem. 2022 Apr 1;13(5):610-621. doi: 10.1039/d1md00403d. eCollection 2022 May 25. RSC Med Chem. 2022. PMID: 35694690 Free PMC article.

3

Design, synthesis and biological evaluation of 3-aryl-7-hydroxy scopoletin derivatives as autophagy activators against tumorigenesis.

Lu X, Zhu C, Zhang C, Li X, Yu Z, Zhang Z, Shi X. Lu X, et al. Among authors: shi x. Eur J Med Chem. 2022 Dec 15;244:114805. doi: 10.1016/j.ejmech.2022.114805. Epub 2022 Oct 7. Eur J Med Chem. 2022. PMID: 36242987

4

Design, synthesis and antiproliferative effect of 17β-amide derivatives of 2-methoxyestradiol and their studies on pharmacokinetics.

Shi X, Wang Z, Xu F, Lu X, Yao H, Wu D, Sun S, Nie R, Gao S, Li P, Xia L, Zhang Z, Wang C. Shi X, et al. Steroids. 2017 Dec;128:6-14. doi: 10.1016/j.steroids.2017.09.013. Epub 2017 Oct 12. Steroids. 2017. PMID: 29031938

5

Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract.

Zhang S, Zhu C, Huang W, Liu H, Yang M, Zeng X, Zhang Z, Liu J, Shi J, Hu Y, Shi X, Wang ZH. Zhang S, et al. Among authors: shi x, shi j. J Control Release. 2023 Aug;360:514-527. doi: 10.1016/j.jconrel.2023.07.005. Epub 2023 Jul 12. J Control Release. 2023. PMID: 37429360 Review.

6

Design, synthesis and activity against drug-resistant bacteria evaluation of C-20, C-23 modified 5-O-mycaminosyltylonolide derivatives.

Zhai H, Luo C, Yang P, Zhang S, Wang H, Cao Y, Yang Y, Liu H, Kong X, Arhema Frejat FO, Ren C, Shi X, Wu C. Zhai H, et al. Among authors: shi x. Eur J Med Chem. 2022 Aug 5;238:114495. doi: 10.1016/j.ejmech.2022.114495. Epub 2022 May 31. Eur J Med Chem. 2022. PMID: 35675753

7

Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition.

Wang C, Li L, Fu D, Qin T, Ran Y, Xu F, Du X, Gao H, Sun S, Yang T, Zhang X, Huo J, Zhao W, Zhang Z, Shi X. Wang C, et al. Among authors: shi x. Eur J Med Chem. 2019 Aug 15;176:135-148. doi: 10.1016/j.ejmech.2019.04.071. Epub 2019 Apr 30. Eur J Med Chem. 2019. PMID: 31102934

8

H₂depda: An acyclic adjuvant potentiates meropenem activity in vitro against metallo-β-lactamase-producing enterobacterales.

Shi XF, Wang MM, Huang SC, Han JX, Chu WC, Xiao C, Zhang E, Qin S. Shi XF, et al. Eur J Med Chem. 2019 Apr 1;167:367-376. doi: 10.1016/j.ejmech.2019.01.083. Epub 2019 Feb 1. Eur J Med Chem. 2019. PMID: 30776696

9

Single-walled carbon nanotubes mediated neovascularity targeted antitumor drug delivery system.

Chen C, Zhang H, Hou L, Shi J, Wang L, Zhang C, Zhang M, Zhang H, Shi X, Li H, Zhang Z. Chen C, et al. Among authors: shi x, shi j. J Pharm Pharm Sci. 2013;16(1):40-51. doi: 10.18433/j3h02c. J Pharm Pharm Sci. 2013. PMID: 23683604 Free article.

10

The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma.

Du B, Wang SY, Shi XF, Zhang CF, Zhang ZZ. Du B, et al. Tumori. 2011 Sep-Oct;97(5):660-5. doi: 10.1177/030089161109700520. Tumori. 2011. PMID: 22158500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,048 results

Search Page

Filters